Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Change in Intangibles: 2017-2024

Historic Change in Intangibles for Ptc Therapeutics (PTCT) over the last 8 years, with Dec 2024 value amounting to $67.7 million.

  • Ptc Therapeutics' Change in Intangibles rose 2364.89% to $252.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $259.0 million, marking a year-over-year increase of 133.80%. This contributed to the annual value of $67.7 million for FY2024, which is 26.51% down from last year.
  • Per Ptc Therapeutics' latest filing, its Change in Intangibles stood at $67.7 million for FY2024, which was down 26.51% from $92.2 million recorded in FY2023.
  • In the past 5 years, Ptc Therapeutics' Change in Intangibles ranged from a high of $120.4 million in FY2022 and a low of $38.1 million during FY2020.
  • Moreover, its 3-year median value for Change in Intangibles was $92.2 million (2023), whereas its average is $93.5 million.
  • As far as peak fluctuations go, Ptc Therapeutics' Change in Intangibles spiked by 110.87% in 2022, and later decreased by 26.51% in 2024.
  • Over the past 5 years, Ptc Therapeutics' Change in Intangibles (Yearly) stood at $38.1 million in 2020, then skyrocketed by 49.78% to $57.1 million in 2021, then skyrocketed by 110.87% to $120.4 million in 2022, then dropped by 23.47% to $92.2 million in 2023, then dropped by 26.51% to $67.7 million in 2024.